Animal data is labelled as such and never presented as equivalent to human trial data
As the pathological burden increases, this metabolic dysregulation may eventually evolve into hepatic fibrosis, cirrhosis, or even further development of hepatocellular carcinoma [75]
Thousands of microbial genomes shed light on interconnected biogeochemical processes in an aquifer system
While the inflammation-reducing and fibrosis-attenuating effects of glucagon agonism are less well-characterized, the reductions in hepatic inflammation parameters and fibrosis observed in preclinical models likely reflect secondary effects consequent to improved steatosis, rather than direct anti-inflammatory actions [21]
Reimer RR, Clark Jr WH, Greene MH, et al
Treatments that could address redox metabolism abnormalities include methylcobalamin with and without folinic acid in open-label studies and vitamin C and N -acetyl-l-cysteine in DBPC studies